Does universal active MRSA surveillance influence anti-MRSA antibiotic use? A retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 12, 2014, Pages 3401-3408

  Jones, Makoto ^a   Huttner, Benedikt ^a,f   Leecaster, Molly ^a   Huttner, Angela ^a,f   Damal, Kavitha ^a   Tanner, Windy ^b   Nielson, Christopher ^c   Rubin, Michael A ^a   Goetz, Matthew Bidwell ^d   Madaras Kelly, Karl ^e   Samore, Matthew H ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Boise VA Medical Center   (United States)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Definitive treatment; Empirical treatment; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY; NOSE SMEAR; ODDS RATIO; PREDICTIVE VALUE; PRESCRIPTION; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; UNITED STATES; VETERAN; DRUG THERAPY; DRUG UTILIZATION; EPIDEMIOLOGICAL MONITORING; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; DRUG THERAPY; DRUG UTILIZATION; EPIDEMIOLOGICAL MONITORING; HOSPITALS, VETERANS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 84946787696     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku299     Document Type: Article

References (31)

1. Rossi F, Diaz L, Wollam A et al. Transferable vancomycin resistance in a community-associated MRSA lineage. N Engl J Med 2014; 370: 1524-31.
2. Jones M, Huttner B, Mayer J et al. Variation of inpatient antibiotic use in acute care facilities of the Veterans Health Administration between 2005 and 2009. In: Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Dallas, TX, 2011. Presentation 377.
3. Jain R, Kralovic SM, Evans ME et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011; 364: 1419-30.
4. Veterans Health Administration. Methicillin-resistant Staphylococcus aureus (MRSA) Initiative. http://www1.va.gov/vhapublications/View Publication.asp?pub_ID=2163.
5. Boyce JM, Pop OF, Abreu-Lanfranco O et al. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillinresistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother 2013; 57: 1163-8.
6. Harris AD, Furuno JP, Roghmann MC et al. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother 2010; 54: 3143-8.
7. Stano P, Avolio M, De Rosa R et al. An antibiotic care bundle approach based on results of rapid molecular screening for nasal carriage of methicillin-resistant Staphylococcus aureus in the intensive care unit. In Vivo 2012; 26: 469-72.
8. Levy ER, Swami S, Dubois SG et al. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010. Infect Control Hosp Epidemiol 2012; 33: 346-53.
9. National Center for Veterans Analysis and Statistics. Trends in the Utilization of VA Programs and Services: FY 2000 to 2012. http://www.va. gov/vetdata/docs/QuickFacts/Utilization_quickfacts_Fy2010_v5.pdf.
10. Jones M, DuVall SL, Spuhl J et al. Identification of methicillin-resistant Staphylococcus aureus within the nation's Veterans Affairs medical centers using natural language processing. BMC Med Inform Decis Mak 2012; 12: 34.
11. Jones M, Huttner B, Madaras-Kelly K et al. Parenteral to oral conversion of fluoroquinolones: low-hanging fruit for antimicrobial stewardship programs? Infect Control Hosp Epidemiol 2012; 33: 362-7.
12. Polk RE, Fox C, Mahoney A et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007; 44: 664-70.
13. Bertrand X, Dowzicky MJ. Antimicrobial susceptibility among gramnegative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Clin Ther 2012; 34: 124-37.
14. Huttner B, Jones M, Huttner A et al. Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system. J Antimicrob Chemother 2013; 68: 2393-9.
15. Glas AS, Lijmer JG, Prins MH et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-35.
16. Senn L, Basset P, Nahimana I et al. Which anatomical sites should be sampled for screening of methicillin-resistant Staphylococcus aureus carriage by culture or by rapid PCR test? Clin Microbiol Infect 2012; 18: E31-3.
17. Lautenbach E, Nachamkin I, Hu B et al. Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider-and patient-collected samples. Infect Control Hosp Epidemiol 2009; 30: 380-2.
18. Yang ES, Tan J, Eells S et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect 2010; 16: 425-31.
19. Kallen AJ, Mu Y, Bulens S et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010; 304: 641-8.
20. Landrum ML, Neumann C, Cook C et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012; 308: 50-9.
21. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009; 64 Suppl 1: i11-7.
22. Pakyz AL, MacDougall C, Oinonen M et al. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med 2008; 168: 2254-60.
23. Finney JW, Humphreys K, Kivlahan DR et al. Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy. Am J Public Health 2011; 101: 1635-42.
24. Cunningham R, Jenks P, Northwood J et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 2007; 65: 24-8.
25. Dulon M, Haamann F, Peters C et al. MRSA prevalence in European healthcare settings: a review. BMC Infect Dis 2011; 11: 138.
26. Huang SS, Rifas-Shiman SL, Warren DK et al. Improving methicillinresistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007; 195: 330-8.
27. Diekema DJ, Pfaller MA, Schmitz FJ et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 Suppl 2: S114-32.
28. Huang SS, Septimus E, Kleinman K et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368: 2255-65.
29. Huskins WC, Huckabee CM, O'Grady NP et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011; 364: 1407-18.
30. Petzel R. Undersecretary for Health's Information Letter: Antimicrobial Stewardship. http://www1.va.gov/vhapublications/ViewPublication.asp? pub_ID=2964.
31. Evans M, Kralovic SM, Jain R. Transmission of resistant bacteria in intensive care. N Engl J Med 2011; 365: 761-6.